Author:
Liu Lei,Zhao Yan,Jia Jia,Chen Hui,Bai Wei,Yang Man,Yin Zhanxin,He Chuangye,Zhang Lei,Guo Wengang,Niu Jing,Yuan Jie,Cai Hongwei,Xia Jielai,Fan Daiming,Han Guohong
Publisher
Springer Science and Business Media LLC
Reference29 articles.
1. de Lope, C. R., Tremosini, S., Forner, A., Reig, M. & Bruix, J. Management of HCC. J Hepatol 56 Suppl 1, S75–87 (2012).
2. Global battle against cancer won’t be won with treatment alone–effective prevention measures urgently needed to prevent cancer crisis. Cent Eur J Public Health 22, 23–28 (2014).
3. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 56, 908–943 (2012).
4. Llovet, J. M. et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359, 378–390 (2008).
5. Zhao, Y. et al. Sorafenib combined with transarterial chemoembolization for the treatment of advanced hepatocellular carcinoma: a large-scale multicenter study of 222 patients. Ann Oncol 24, 1786–1792 (2013).
Cited by
37 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献